Stock listing
Acrux Limited
Selected listing: ACR · ASX · AUD · AU
Acrux Limited (ASX:ACR), Health Technology. Latest release Oct 1, 2026: Acrux has received $1.977m RDTI rebate for FY26.
- Ticker
- ASX:ACR
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- ASX
- Currency
- AUD
About Acrux Limited
The company focuses on developing and commercializing innovative pharmaceutical products. Acrux is known for its expertise in transdermal drug delivery systems.
Latest news from Acrux Limited
Acrux has received $1.977m RDTI rebate for FY26
October 1, 2026
FY26 Annual Report and Appendix 4E
August 25, 2026
Investor Presentation - Female Testosterone for HSDD
August 5, 2026
Update - Licensing Lenzetto for Australia for AUD5.4m
May 28, 2026
Acrux licenses Lenzetto for Australian market for AUD5.4m
May 27, 2026